Long-term follow up of angiofibromas treated with CO2 laser in 23 patients with tuberous sclerosis;Seguimiento a largo plazo de angiofibromas tratados con láser de CO2 en 23 pacientes con esclerosis tuberosa

Actas Dermo-Sifiliograficas

Volumn 96, Issue 8, 2005, Pages 498-503

  Belmar, Paulina ^a,b   Boixeda, Pablo ^a   Baniandrés, Ofelia ^a   Fernández Lorente, Manuel ^a   Arrazola, J Ma ^a  

^a Hospital Universitario Pamón y Cajal Madrid   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Angiofibromas; Laser; Treatment; Tuberous sclerosis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CARBON DIOXIDE LASER; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HAMARTOMA; HEMANGIOFIBROMA; HUMAN; KAPLAN MEIER METHOD; MALE; RECURRENCE RISK; RETROSPECTIVE STUDY; SCHOOL CHILD; SKIN MANIFESTATION; STATISTICAL ANALYSIS; TUBEROUS SCLEROSIS;

EID: 29044445049     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-7310(05)73121-5     Document Type: Article

References (19)

1. Hurst JS, Wilcoshi S. Recognizing an index case of tuberous sclerosis. Am Fam Physician. 2000;61:703-8.
2. Osborne JP, Fryer AE, Webb D. Epidemiology of tuberous sclerosis. Ann NY Acad Sci. 1991;615:125-7.
3. Fryer AE, Chalmers A, Connor JM, et al. Evidence that the gene for tuberous esclerosis is on chromosome 9. Lancet. 1987;1:659-61.
4. The European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis chromosome 16. Cell. 1993;75:1305-15.
5. Povey S, Burley MW, Attwood J, et al. Two loci for tuberous sclerosis: one on 9q34 and one on 16p13. Ann Hum Genet. 1994;58:107-27.
6. Roach ES, Gómez MR, Northrup H. Tuberous Sclerosis consensus conference: revised clinical diagnostic criteria. J Child Neurol. 1998;13:624-8.
7. Verheyden CN. Treatment of the facial angiofibromas of tuberous sclerosis. Plast Reconstr Surg. 1996;98:777-83.
8. 2 laser with flashscanner. Dermatol Surg. 1999;25:970-3.
9. Janniger CK, Goldberg DJ. Angiofibromas in Tuberous sclerosis: comparison of treatment by carbon dioxide and argon laser. J Dermatol Surg Oncol. 1990;16:317-20.
10. Kaufman AJ, Grekin RC, Geisse JK, Frieden IJ. Treatment of adenoma sebaceum with copper vapor laser. J Am Acad Dermatol. 1995;33:770-4.
11. Hoffman SJ, Walsh P, Morelli JG. Treatment of angiofibroma with the pulsed tunable dye laser. J Am Acad Dermatol. 1993;29:790-1.
12. 2, Argon and pulsed dye laser treatment of angiofibromas. J Dermatol Surg Oncol. 1994;20: 808-12.
13. Webb D, Osborne JR. Tuberous sclerosis. Arch Dis Child. 1995;72:471-4.
14. Cisneros JL, Camacho F. Láser y fuentes de luz pulsada intensa en dermatología y dermocosmética. Madrid: Grupo Aula Médica; 2000.
15. Hruza GJ. Laser treatment of epidermal and dermal lesions. Dermatol Clin. 1997;15:487-506.
16. Camacho F, García-Hernández J, Pérez-Bernal AM. Modelación cutánea (resurfacing): Concepto y fundamentos. En: Cisneros JL, Camacho F, editores. Laser y fuentes de luz pulsada intensa en dermatología y dermocosmética. Madrid: Grupo Aula Médica S.A.; 2000.
17. 2 laser resurfacing. Dermatol Clin. 2002;20:77-85.
18. Bittencourt RC, Huilgol SC, Seed PT, Calonje E, Markey AC, Barlow RY. Treatment of angiofibromas with a scanning carbon dioxide laser: A clinicopathologic study with long-term follow-up. J Am Acad Dermatol. 2001;45: 735-5.
19. Papavid E, Markey A, Bellaney G, Walker NPJ. Carbon dioxide and pulsed dye laser treatment of angiofibromas in 29 patients with tuberous sclerosis. Br J Dermatol. 2002; 147:337-42.